Blog
- News/
Faces of Future: Dr. Ingmar Schuster
Ingmar Schuster, Exazyme CEO, pioneers AI-driven protein development at Startup Villa, revolutionizing industries for sustainability and efficiency.
Read More
- News/
Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.
Richard Socher, AI expert and AIX Ventures founding partner, anticipates top-tier solutions with Exazyme’s blend of expertise and advanced algorithms.
Read More
- News/
DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden
Exazyme, Berlin-based AI-Biotech startup, secures €2M Series A funding from AIX Ventures & Atlantic Labs. Discover how we revolutionize Protein Design.
Read More
- News/
Never give up and always believe in your own mission!
Explore Exazyme’s discourse with Startup Valley, delving into insights, challenges, and pivotal roles. Uncover the transformative impact of our AI technology on enzyme development.
Read More
- News/
Exazyme secures €2 million in funding for AI-assisted protein development
The Berlin-based start-up Exazyme has won over two renowned venture capitalists, AIX Ventures and Atlantic Labs, and received €2 million in seed capital.
Read More
- Success Story/
Machine Learning-Guided Enzyme Engineering: Improving CO2-Fixation rate of Glycolyl-CoA Carboxylase
Exazyme is changing the way scientists discover and design new proteins. Our AI-based app creates a list of novel protein variants that you can test in the wet lab. ➡️ Save weeks of manual modeling ➡️ Focus on more important research tasks
Read More